The GMRF recommends moving from basic-level controls (law, classification, essential principles, declaration of conformity, QMS, labelling, advertising, exceptional situations, establishment registration, listing, import controls, adverse event reporting, FSCA notification, withdrawal, safety alerts and market surveillance) to expanded-level controls (clinical investigation oversight, CAB oversight, recognised standards, nomenclature, UDI, advertising review, QMS audits, submission review, post-market surveillance review, market surveillance systems, inspections, local production and regulatory testing) only once the basic ones are effectively enforced, the law provides for them and resources are available, implementing expanded elements stepwise according to national priorities.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.